Short Interest in JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Drops By 17.8%

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the recipient of a significant decrease in short interest in June. As of June 15th, there was short interest totalling 447,000 shares, a decrease of 17.8% from the May 31st total of 544,000 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

JCR Pharmaceuticals Stock Performance

JCRRF stock remained flat at $5.22 during midday trading on Tuesday. The company’s 50 day simple moving average is $5.22 and its 200-day simple moving average is $6.69. JCR Pharmaceuticals has a twelve month low of $5.22 and a twelve month high of $6.20.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.